Stereotactic body radiation therapy (SBRT) in the treatment of liver metastases: State of the art;Radiothérapie en conditions stéréotaxiques des métastases hépatiques

Cancer/Radiotherapie

Volumn 15, Issue 1, 2011, Pages 72-76

  De Bari, B ^a,b   Guillet, M ^a,b   Mornex, F ^a,b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Liver metastases; NTCP; Radiotherapy; SBRT; Stereobody radiation therapy; Tolerance

Indexed keywords

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CRYOTHERAPY; DISEASE COURSE; HUMAN; LIVER METASTASIS; LIVER SURGERY; PRIORITY JOURNAL; PROGNOSIS; RADIATION INJURY; RADIOFREQUENCY ABLATION; SHORT SURVEY; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT OUTCOME;

HUMANS; LIVER NEOPLASMS; RADIOSURGERY;

EID: 79551512062     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2010.11.005     Document Type: Short Survey

References (45)

1. Gilbert HA, Kagan AR. Metastases: incidence, detection and evaluation without histological confirmation. In: Weiss L, editor. Fundamental aspects of metastases. North Holland, Amsterdam, The Netherlands; 1976. p. 385-405.
2. Weiss L., Grundmann E., Torhost J., Hartveit F., Moberg I., Eder M., et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 1986, 150:195-203.
3. Meyerhardt J.A., Mayer R.J. Drug therapy: Systemic therapy for colorectal cancer. N Engl J Med 2005, 352:476-487.
4. Abdalla E.K., Vauthey J.N., Ellis L.M., Ellis V., Pollock G., Broglio K.R., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004, 239:818-825. [discussion 825-7].
5. Bozzetti F., Cozzaglio L., Baracchi P., Marubini E., Doci R., Bignami P., et al. Comparing surgical resection of limited hepatic metastases from colorectal cancer to non-operative treatment. Eur J Surg Oncol 1993, 19:162-167.
6. Choti M.A., Sitzmann J.V., Tiburi M.F., Sumetchotimetha W., Rangsin R., Schulick R.D., et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002, 235:759-766.
7. Fong Y., Blumgart L.H., Cohen A.M. Surgical treatment of colorectal metastases to the liver. CA Cancer J Clin 1995, 45:50-62.
8. Scheele J., Stangl R., Altendorf-Hoffmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 1990, 77:1241-1246.
9. Fong Y., Fortner J., Sun R.L., Brennan M.F., Blumgart L.H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999, 230:309-318.
10. Gilliams A.R. Liver ablation therapy. Br J Radiol 2004, 77:713-723.
11. Golberg S.N., Gazelle G.S., Dawson S.L., Rittman W.J., Mueller P.R., Rosenthal D.I. Tissue ablation with radiofrequency: effect of probe size, gauge, duration and temperature on lesion volume. Acad Radiol 1995, 2:399-404.
12. Livraghi T., Golberg S.N., Monti F., Bizzini A., Lazzaroni S., Meloni F., et al. Saline-enhanced radiofrequency tissue ablation in the treatment of liver metastases. Radiology 1997, 202:205-210.
13. Goldberg S., Gazelle G., Dawson S. Radiofrequency tissue ablation with radiofrequency increased lesion diameter with a perfusion electrode. Acad Radiol 1996, 3:636-644.
14. De Baere T., Risse O., Kuoch V., Dromain C., Sengel C., Smayra T., et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 2003, 181:695-700.
15. Mulier S., Mulier P., Ni Y., Miao Y., Dupas B., Marchal G., et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002, 89:1206-1222.
16. Ingold J.A., Reed G.B., Kaplan H.S., Bagshaw M.A. Radiation hepatitis. AJR Am J Roentgenol 1965, 93:200-208.
17. Kallman P., Agren A., Brahme A. Tumour and normal tissue responses to fractionated non-uniform dose delivery. Int J Radiat Biol 1992, 62:249-262.
18. Kutcher G.J., Lawrence T.S. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys 1995, 31:883-891.
19. Dawson L.A., Normolle D., Balter J.M., McGinn C.J., Lawrence T.S., Ten Haken R.K. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 2002, 53:810-821. [Erratum in Int J Radiat Oncol Biol Phys 2002;53:1422. Comment in: Int J Radiat Oncol Biol Phys 2004;58:1318-9, author reply 1319-20].
20. Mornex F., Girard N., Beziat C., Kubas A., Khodri M., Trepo C., et al. Feasibility and efficacy of high-dose three-dimensional radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies - mature results of the French phase II RTF-1 trial. Int J Radiat Oncol Biol Phys 2006, 66:1152-1158.
21. Niibe Y., Hayakawa K. Oligometastases and Oligorecurrence: the new era of cancer therapy. Jpn J Clin Oncol 2010, 40:107-111.
22. Borgelt B.B., Gelber R., Brady L.W., Griffin T., Hendrickson F.R., et al. The palliation of hepatic metastases: results of the Radiation Therapy Oncology Group pilot study. Int J Radiat Oncol Biol Phys 1981, 7:587-591.
23. Lawrence T.S., Tesser R.J., Ten Haken R.K. An application of dose volume histograms to the treatment of intrahepatic malignancies with radiation therapy. Int J Radiat Oncol Biol Phys 1990, 19:1041-1047.
24. Prasad B., Lee M.S., Hendrickson F.R. Irradiation of hepatic metastases. Int J Radiat Oncol Biol Phys 1977, 2:129-132.
25. Sherman D.M., Weichselbaum R., Order S.E., Cloud L., Trey C., Piro A.J. Palliation of hepatic metastasis. Cancer 1978, 41:2013-2017.
26. Chiou S.Y., Lee R.C., Chi K.H., Chia-Hsien Cheng J., Chiang J.H., Chang C.Y. The triple-phase CT image appearance of post-irradiated livers. Acta Radiol 2001, 42:526-531.
27. Lawrence T.S., Robertson J.M., Anscher M.S., Jirtle R.L., Ensminger W.D., Fajardo L.F. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 1995, 31:1237-1248.
28. Emami B., Lyman J., Brown A., Coia L., Goitein M., Munzenrider J.E., et al. Tolerance of normal tissue to therapeutic radiation. Int J Radiat Oncol Biol Phys 1991, 21:109-122.
29. Kehwar T.S. Analytical approach to estimate normal tissue complication probability using best fit of normal tissue tolerance doses into the NTCP equation of the linear quadratic model. J Cancer Res Ther 2005, 1:168-179.
30. Lawrence T.S., Ten Haken R.K., Kessler M.L., Robertson J.M., Lyman J.T., Lavigne M.L., et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 1992, 23:781-788.
31. Dawson L.A., Ten Haken R.K., Lawrence T.S. Partial irradiation of the liver. Semin Radiat Oncol 2001, 11:240-246.
32. Dawson L.A., Ten Haken R.K. Partial volume tolerance of the liver to radiation. Semin Radiat Oncol 2005, 15:279-283.
33. Dawson L.A. The evolving role of radiation therapy in hepatocellular carcinoma. Cancer Radiother 2008, 12:96-101.
34. De Bari B., Pointreau Y., Rio E., Mirabel X., Mornex F. Dose de tolérance à l'irradiation des tissus sains: le foie. Cancer Radiother 2010, 14:344-349.
35. Quivrin M., Mornex F., Enachescu C., Martin E., Ligey-Bartolomeu A., Nouhaud E., et al. Tumeurs primitives hépatiques. Cancer Radiother 2010, 14:S103-S110.
36. McCammon R., Schefter T.E., Gaspar L.E., Zaemisch R., Gravdahl D., Kavanagh B. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2009, 73:112-118.
37. Kubas A., Mornex F., Merle P., d'Hombres A., Lorchel F., Chapet O. L'irradiation des carcinomes hépatocellulaires: impact de la respiration sur les mouvements et variations de volume de la tumeur, du foie et des organes intra-abdominaux. Cancer Radiother 2008, 12:768-774.
38. Milano M.T., Constine L.S., Okunieff P. Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol 2008, 3:36. [review article].
39. Rustoven K.E., Kavanagh B.D., Cardenes H., Stieber V.W., Burri S.H., Feigenberg S.J., et al. Multi-institutional Phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009, 27:1579-1584.
40. Herfarth K.K., Debus J. Stereotactic radiation therapy for liver metastases. Chirurg 2005, 76:564-569. [article in German].
41. Hoyer M., Roed H., Traber Hansen A., Ohlhuis L., Petersen J., Nellemann H., et al. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 2006, 45:823-830.
42. Milano M.T., Katz A.W., Muhs A.G., Philip A., Buchholz D.J., Schell M.C., et al. A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer 2008, 112:650-658.
43. Méndez Romero A., Wunderink W., Hussain S.M., De Pooter J.A., et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase I-II study. Acta Oncol 2006, 45:831-837.
44. Wulf J., Guckenberger M., Haediger U., Oppitz U., Mueller G., Baier K., et al. Stereotactic radiotherapy of primary liver cancers and hepatic metastases. Acta Oncol 2006, 45:838-847.
45. Lee M.T., Kim J.J., Dinniwell R., Brierley J., Lockwood G., Wong R., et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 2009, 27:1585-1591.